Hormone sensitive protocol for metastatic prostate cancer, an update

被引：0
|
作者：
Ossorioa, J. L. Alvarez [1 ,2 ,3 ]
Aliagac, M. Rodrigo [4 ]
Antolind, A. Rodriguez [5 ]
Urzaize, M. Unda [6 ]
Callejaf, M. A.
Ruizg, M. de la Cruz [7 ]
Quilezh, J. Blas [8 ]
Millani, I. R. Hernandez [9 ]
Zalabardoj, D. Sanchez [10 ]
Olmo, J. M. Cozar
机构：
[1] Hosp Univ Puerta Mar, Serv Urol, Cadiz, Spain
[2] Asociac Espanola Urol AEU, Madrid, Spain
[3] Fdn Invest Urol FIU, Madrid, Spain
[4] Hosp Gen Univ Castellon, Serv Urol, Castellon de La Plana, Spain
[5] Hosp Univ 12 Octubre, Serv Urol, Madrid, Spain
[6] Hosp Univ Basurto, Serv Urol, Bilbao, Vizcaya, Spain
[7] Hosp Son Espases, Serv Urol, Palma De Mallorca, Baleares, Spain
[8] Hosp Univ Virgen Salud, Complejo Hosp Toledo, Toledo, Spain
[9] Hosp Univ Albacete, Albacete, Spain
[10] Hosp Reina Sofia, Navarra, Spain
来源：
ACTAS UROLOGICAS ESPANOLAS | 2023年 / 47卷 / 04期
关键词：
Androgen deprivation therapy; Clinical follow-up; Hormone sensitive metastatic prostate cancer; Treatment; ANDROGEN DEPRIVATION THERAPY;
D O I：
10.1016/j.acuro.2022.09.003
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
To review and update last protocols in hormone sensitive metastatic prostate cancer for improving clinical management in routine. Evidence analysis available about recent updates protocols in hormone sensitive metastatic prostate cancer according to expert panel of clini-cians about this field. A nominal consensus group for unify and improve the recommendations to the management of sensitive metastatic prostate cancer patients is currently needed. This document unifies and improve the management of patients with hormone sensitive metastatic prostate cancer, with a methodology that combines data quantitative and qualitative and based on the participation of a broad scientific committee appointed by the Spanish Association of Urology. (c) 2022 AEU. Published by Elsevier Espan similar to a, S.L.U. All rights reserved.
引用
收藏
页码：244 / 249
页数：6
相关论文
共 50 条
  • [21] Advancements in the treatment of metastatic hormone-sensitive prostate cancer
    Li, Hengping
    Zhang, Mao
    Wang, Xiangrong
    Liu, Yang
    Li, Xuanpeng
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [22] Diagnosis and staging of metastatic hormone-sensitive prostate cancer
    Krausewitz, Philipp
    Ritter, Manuel
    Essler, Markus
    UROLOGIE, 2023, 62 (04): : 347 - 353
  • [23] Metastatic hormone sensitive prostate cancer: local treatment strategies
    Jochen Walz
    Geraldine Pignot
    Sami Fakhfakh
    Jennifer Campagna
    Mathilde Guerin
    Cecile Vicier
    Serge Brunelle
    Naji Salem
    Gwenaelle Gravis
    World Journal of Urology, 2021, 39 : 327 - 337
  • [24] Importance of radiotherapy to the primary in metastatic hormone sensitive prostate cancer
    Elisha T. Fredman
    Gordon Guo
    Daniel E. Spratt
    Prostate Cancer and Prostatic Diseases, 2021, 24 : 929 - 930
  • [25] Darolutamide: A Review in Metastatic Hormone-Sensitive Prostate Cancer
    Arnold Lee
    Targeted Oncology, 2023, 18 : 793 - 800
  • [26] Optimal treatment for metastatic hormone-sensitive prostate cancer
    Omlin, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 18 - 19
  • [27] Systemic therapy in metastatic hormone-sensitive prostate cancer
    McDonald, Jodie
    O'Brien, Jonathan
    Kostos, Louise
    Lawrentschuk, Nathan
    Azad, Arun A.
    Murphy, Declan
    Chen, Kenneth
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2022, 16 (04) : 234 - 239
  • [28] Treatment options for metastatic hormone-sensitive prostate cancer
    Kostos, Louise
    Murphy, Declan G.
    LANCET ONCOLOGY, 2022, 23 (10): : 1234 - 1235
  • [29] Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer
    Smith, Matthew R.
    Hussain, Maha
    Saad, Fred
    Fizazi, Karim
    Sternberg, Cora N.
    Crawford, E. David
    Kopyltsov, Evgeny
    Park, Chandler H.
    Alekseev, Boris
    Montesa-Pino, Alvaro
    Ye, Dingwei
    Parnis, Francis
    Cruz, Felipe
    Tammela, Teuvo L. J.
    Suzuki, Hiroyoshi
    Utriainen, Tapio
    Fu, Cheng
    Uemura, Motohide
    Mendez-Vidal, Maria J.
    Maughan, Benjamin L.
    Joensuu, Heikki
    Thiele, Silke
    Li, Rui
    Kuss, Iris
    Tombal, Bertrand
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (12): : 1132 - 1142
  • [30] Modern treatment of metastatic hormone-sensitive prostate cancer
    Kuronya Zsofia
    Biro Krisztina
    Geczi Lajos
    Maraz Aniko
    ORVOSI HETILAP, 2018, 159 (41) : 1664 - 1671
12345